XTX Topco’s Precision BioSciences DTIL Stock Holding History

XTX Topco’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$96K	Buy	+12,219	New	+$86K	﹤0.01%	3546
2026 Q1	–	Sell	-35,929	Closed	-$149K	–	3942
2025 Q4	$149K	Buy	+35,929	New	+$204K	﹤0.01%	2499
2025 Q1	–	Sell	-17,706	Closed	-$67.5K	–	2564
2024 Q4	$67.5K	Buy	+17,706	New	+$129K	0.01%	1844
2024 Q1	–	Sell	-407	Closed	-$4.46K	–	1945
2023 Q4	$4.46K	Buy	+407	New	+$4.39K	﹤0.01%	1482
2023 Q1	–	Sell	-2,786	Closed	-$99.5K	–	1368
2022 Q4	$99.5K	Sell	2,786 -2,882	-51%	-$114K	0.02%	1001
2022 Q3	$221K	Buy	5,668 +2,941	+108%	+$140K	0.05%	720
2022 Q2	$131K	Buy	2,727 +1,954	+253%	+$115K	0.05%	578
2022 Q1	$71K	Buy	+773	New	+$105K	0.03%	557

Other funds holding DTIL

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

XTX Topco's DTIL Position: Q2 2026 in Review

XTX Topco opened a new position in Precision BioSciences (DTIL) in Q2 2026: 12,219 shares worth $96K. The stake represents ﹤0.01% of the portfolio and ranks #3546 among its holdings. This is a return to the name: XTX Topco previously reported a position in DTIL as recently as Q4 2025.

XTX Topco first reported a position in DTIL in Q1 2022 and has held it in 8 quarters since. The position peaked at $221K in Q3 2022. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

XTX Topco held 12,219 shares of Precision BioSciences worth $96K as of Q2 2026.
Precision BioSciences was a new XTX Topco position in Q2 2026.
Precision BioSciences made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3546 holding.
XTX Topco first reported a position in Precision BioSciences in Q1 2022 and has held it in 8 quarters since.
XTX Topco's Precision BioSciences position peaked at $221K in Q3 2022.
95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.